enGene Holdings ENGN 深滬

等待開盤 04-01 09:30:00 美东时间

6.81

+0.630

+10.19%

華盛通

立即下載

最高6.98
今開6.29
成交量 24.42万股
最低 6.29
昨收 6.18
總市值 4.56亿
52周最高 12.25
市盈率 ^靜 --
換手率 0.00%
52周最低 2.65
委比 -51.59%
總股本 6698.95万
歷史最高 43.00
量比 1.80
振幅 11.17%
歷史最低 2.65
每手 1
風險率 2.41%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级

今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元

03-12 12:34
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价

今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元

03-10 15:05
enGene Holdings GAAP EPS of $0.44

enGene Holdings press release (ENGN): Q1 GAAP EPS of $0.44. As of January 31, 2026, cash, cash equivalents and marketable securities were $312.5 million. Total operating expenses were $31.2 million fo...

03-10 01:25
HC Wainwright & Co. Reiterates Buy on enGene Holdings, Maintains $25 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates enGene Holdings (NASDAQ:ENGN) with a Buy and maintains $25 price target.

03-09 23:54
enGene Holdings shares are trading lower. The company reported Q1 financial results.

enGene Holdings shares are trading lower. The company reported Q1 financial res...

03-09 22:18
BRIEF-Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares

BRIEF-Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares March 9 (Reuters) - enGene Holdings Inc ENGN.O : ENGENE HOLDINGS INC - ENTERS SALES AGREEMENT WITH LEERINK PARTNERS TO SELL COMMON SHARES - SEC FILING ENGENE HOLDINGS INC - SALES AGREEMENT ALLOWS OFFERING OF COM

03-09 19:25
enGene Holdings Q1 EPS $(0.44) Beats $(0.58) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.58) by 24.53 percent. This is a 8.33 percent increase over losses of $(0.48) per share from

03-09 19:18
BRIEF-enGene Reports First Quarter 2026 Financial Results and Provides Business Update

BRIEF-enGene Reports First Quarter 2026 Financial Results and Provides Business Update March 9 (Reuters) - enGene Holdings Inc ENGN.O : ENGENE REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE ENGENE HOLDINGS Q1 NET LOSS $0.44 PER SHARE Source text: ID:nBw1VS3cwa Further comp

03-09 19:18
enGene extends momentum with another 14% surge on Friday

enGene Holdings Inc. (ENGN) climbed another 14% on Friday, adding to gains posted over the previous two sessions. Earlier in the week, the company announced an expanded debt facility, helping the stoc...

01-24 05:08
enGene Holdings GAAP EPS of $2.29

enGene Holdings press release (ENGN): FY GAAP EPS of $2.29. Full Year Financial Results ended October 31, 2025Total operating expenses were $123.2 million for the full year ended October 31, 2025, com...

2025-12-23 05:05

派息除權日	每股總股息	派息日期
2015-08-03	0.13	2015-08-07
2015-07-01	0.13	2015-07-08
2015-06-01	0.13	2015-06-05
2015-05-01	0.12	2015-05-07
2015-04-01	0.13	2015-04-08
2015-03-02	0.12	2015-03-06
2015-02-02	0.13	2015-02-06
2014-12-24	0.13	2014-12-31
2014-12-01	0.14	2014-12-05
2014-11-03	0.15	2014-11-07
2014-10-01	0.15	2014-10-07
2014-09-02	0.13	2014-09-08
2014-08-01	0.12	2014-08-07
2014-07-01	0.13	2014-07-08
2014-06-02	0.13	2014-06-06
2014-05-01	0.13	2014-05-07
2014-04-01	0.12	2014-04-07
2014-03-03	0.12	2014-03-07
2014-02-03	0.12	2014-02-07
2013-12-26	0.12	2014-01-02
2013-12-02	0.12	2013-12-06
2013-11-01	0.12	2013-11-07
2013-10-01	0.12	2013-10-07
2013-09-03	0.12	2013-09-09
2013-08-01	0.12	2013-08-07
2013-07-01	0.11	2013-07-08
2013-06-03	0.11	2013-06-07
2013-05-01	0.11	2013-05-07
2013-04-01	0.11	2013-04-05
2013-03-01	0.12	2013-03-07
2013-02-01	0.11	2013-02-07
2012-12-26	0.11	2013-01-02
2012-12-03	0.11	2012-12-07
2012-11-01	0.12	2012-11-07
2012-10-01	0.12	2012-10-05
2012-09-04	0.12	2012-09-10
2012-08-01	0.12	2012-08-07
2012-07-02	0.11	2012-07-09
2012-06-01	0.11	2012-06-07
2012-05-01	0.12	2012-05-07
2012-04-02	0.17	2012-04-09

公司名稱	Forbion European Acquisition Corp.
行業分類	Financial Conglomerates
業務描述	enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

enGene Holdings ENGN 深 滬

6.81

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

enGene Holdings ENGN 深滬